A33-TCO	trans-Cyclooctene-modified humanized anti-a differentiation antigen (A33) monoclonal antibody
Ac4GalNAz	N-Azidoacetylgalactosamine tetraacylated
Ac3ManNAz	1,3,4-Tri-O-acetyl-N-azidoacetylmannosamine
Ac4ManNAz	N-Azidoacetylmannosamine tetraacylated
ADCs	Monoclonal antibody-drug conjugates
ADIBO	Azadibenzocyclooctyne
ASCs	Adipose-derived mesenchymal stem cells
BCN	Bicyclo[6.1.0]nonyne
BCN-Ce6-CNPs	Glycol chitosan nanoparticle conjugated with bicyclo[6.1.0]nonyne and chlorine e6
BCN-CNPs	Bicyclo[6.1.0]nonyne modified imageable glycol chitosan nanoparticle
CC49	Anti-tumor associated glycoprotein 72 monoclonal anti body
CC49-TCO-DOX	CC49 conjugate with doxorubicin (DOX) via trans-cyclooctene linker
CEA	Carcinoembryonic antigen
CT	Computed tomography
CuAAC	Copper (I)-catalyzed azide-alkyne 1,3-dipolar cycloaddition
DBCO	Dibenzyl cyclooctyne-
DBCO-650	Dibenzyl cyclooctyne-SETA 650
DBCO-liposome	Dibenzyl cyclooctyne conjugated PEGylated liposome
DBCO-NPs	Dibenzyl cyclooctyne-modified poly (lactide-co-glycolide) nanoparticles
DBCO-VC-Dox	Dibenzyl cyclooctyne-valine-cysteine-doxorubicin conjugate
DCL-AAM	Histone deacetylase/cathepsin l-responsive acetylated azidomannose
DIFO	Difluorinated cyclooctyne
DOTA	1,4,7,10-Tetraazacyclododecane- N,N’,N”,N’”-tetraacetic acid
DOX	Doxorubicin
EGFR	Epidermal growth factor receptor
EPR	Enhanced permeability and retention
HER-2	Human epidermal growth factor receptor 2
iEDDA	Inverse electron demand Diels-Alder
mAb	Monoclonal antibodies
MR	Magnetic resonance
MSCs	Mesenchymal stem cells
Nano-MPs	Nano-sized metabolic precursors
NIR	Near-infrared
NOTA	1,4,7-Triazacyclononane-N,N′,N”-triacetic acid
OCT	Cyclooctyne
PEG	Poly(ethylene glycol)
PET	Positron emission tomography
PLGA	Poly (lactide-co-glycolide)
PSA	Prostate-specific antigen
RI	Radio isotope
RR-S-Ac3ManNAz	Arg-Arg-p-aminobenzyloxycarbonyl-1,3,4-tri-O-acetyl-N-azidoacetylmannosamine
SPAAC	Strain-promoted [3 + 2] azide-alkyne cycloaddition
SPECT	Single-photon emission computed tomography
TAG72	Tumor associated glycoprotein 72
TCO	trans-Cyclooctene
TCO-anti-VEGFR2	trans-Cyclooctene-conjugated anti-vascular endothelial growth factor receptor 2
Tz	Tetrazines